For Media

Argos Therapeutics, Inc. is developing fully personalized immunotherapies that target unique features of a patient’s disease. This new generation of personalized therapeutics trains the immune system to recognize and attack diseases. Argos’ scientific leadership in RNA-loaded dendritic cells and advanced manufacturing processes provide a platform that we believe can tackle a wide range of cancers and infectious diseases.

817074816150814013812565811415806480804758804480804027802241c3112c58-eb52-4515-b778-ed0eefe8cdcdcf9e0033-2d30-4556-952b-62134d6d66aac2848a4a-9c02-4194-878f-953bb35636df5a8f8a6d-cb94-403f-8568-5ecf1acf88d58f31fd07-f2ab-4fbc-a61f-4ceb845956f8df73e933-0850-4d45-b115-ad2c4ba43be5fd539e46-a93e-4135-8451-389b13848f49579711c5-13b8-4c50-9b2d-2f2a67330e1e86d42f2b-1bdf-4002-8db3-ef006efa0da64f5413fd-18e2-4f43-bb73-16fb90627c36ARGS_News_2015_3_20_General_Releases.pdfARGS_News_2015_3_16_General_Releases.pdfARGS_News_2015_3_4_General_Releases.pdfARGS_News_2015_2_27_General_Releases.pdfARGS_News_2015_2_24_General_Releases.pdfARGS_News_2015_2_2_General_Releases.pdfARGS_News_2015_1_23_General_Releases.pdfARGS_News_2015_1_22_General_Releases.pdfARGS_News_2015_1_20_General_Releases.pdfARGS_News_2015_1_9_General_Releases.pdf19990172011563717390170521432417524191861773420325123456789102015-3-20T8:30:0-4:02015-3-16T16:30:0-4:02015-3-4T16:30:0-4:02015-2-27T8:30:0-4:02015-2-24T8:30:0-4:02015-2-2T16:30:0-4:02015-1-23T11:0:0-4:02015-1-22T8:30:0-4:02015-1-20T8:30:0-4:02015-1-9T7:0:0-4:0902658901854900038898870897956894187892671892460892000890486General ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesGeneral ReleasesDr. Mark DeBenedette Will Review Outcomes From a Phase IIb Clinical Trial of Investigational Immunotherapy for the Treatment of HIVPrincipal Investigator Dr. Robert Figlin to Provide Updates on Phase 2 AGS-003 Plus Sunitinib Experience and Highlight Progress for Ongoing ADAPT Phase 3 TrialDr. Fred Miesowicz Will Present a Case Study Review of Logistics of Cell Therapy Manufacturing on January 26th and Will Participate in a Breakfast Briefing on January 27thDr. Mark DeBenedette Will Discuss the Use of Multi-Color Flow Cytometry to Monitor T-Cell Responses During the 7th Immunotherapeutics and Immunomonitoring Conference on January 29th in San DiegoDr. Charles Nicolette Will Discuss Immunotherapy for Cancer Treatment on January 27thArgos Therapeutics Director of Immunology to Present at HIV Vaccines MeetingArgos Therapeutics to Hold Fourth Quarter and Year-End 2014 Financial Results Conference Call on Monday, March 30, 2015Argos Therapeutics to Present at Three Upcoming Investor Conferences in MarchArgos Therapeutics Announces Update on Phase 3 ADAPT Trial to be Presented During 2015 ASCO Genitourinary Cancers SymposiumJoan C. Winterbottom Joins Argos Therapeutics as Chief Human Resources OfficerArgos Therapeutics to Present at the 17th Annual BIO CEO & Investor ConferenceArgos Therapeutics Chief Operating Officer to Speak at Phacilitate Cell & Gene Therapy Forum 2015Argos Therapeutics Director of Immunology to Speak at the GTCbio Novel Immunotherapeutics Summit 2015Argos Therapeutics Chief Scientific Officer to Speak at the Personalized Medicine World Conference 2015Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized Immunotherapy for the Treatment of HIV878787878787878787872015201520152015201520152015201520152015No Error0

Argos Therapeutics Director of Immunology to Present at HIV Vaccines Meeting
Read more

Argos Therapeutics to Hold Fourth Quarter and Year-End 2014 Financial Results Conference Call on Monday, March 30, 2015
Read more

Argos Therapeutics to Present at Three Upcoming Investor Conferences in March
Read more

Argos Therapeutics Announces Update on Phase 3 ADAPT Trial to be Presented During 2015 ASCO Genitourinary Cancers Symposium
Read more

Joan C. Winterbottom Joins Argos Therapeutics as Chief Human Resources Officer
Read more

Argos Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference
Read more

Argos Therapeutics Chief Operating Officer to Speak at Phacilitate Cell & Gene Therapy Forum 2015
Read more

Argos Therapeutics Director of Immunology to Speak at the GTCbio Novel Immunotherapeutics Summit 2015
Read more

Argos Therapeutics Chief Scientific Officer to Speak at the Personalized Medicine World Conference 2015
Read more

Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized Immunotherapy for the Treatment of HIV
Read more